New perspectives on the endothelin axis in pain

Pharmacological Research

Volumn 63, Issue 6, 2011, Pages 532-540

  Barr, Travis P ^a   Kam, Sarah ^a   Khodorova, Alla ^a   Montmayeur, Jean Pierre ^a,b   Strichartz, Gary R ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CENTRE DES SCIENCES DU GOÛT ET DE L ALIMENTATION   (France)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cancer; Heterodimers; Ion channels; Pain; Signal transduction; TRPV1

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; 4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; ACETYLSALICYLIC ACID; ATRASENTAN; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR AGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N ACETYL 3,3 DIPHENYL DEXTRO ALANYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE]; SARAFOTOXIN S6B; SARAFOTOXIN S6C; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; VANILLOID RECEPTOR 1;

ALLODYNIA; ANTINOCICEPTION; CALCIUM CELL LEVEL; CANCER PAIN; CELL FUNCTION; CHRONIC PAIN; COMPLEX REGIONAL PAIN SYNDROME; DISEASE SEVERITY; DRUG ANTAGONISM; DRUG POTENCY; DRUG POTENTIATION; HUMAN; HYPERALGESIA; INTRACELLULAR SIGNALING; ION CURRENT; KERATINOCYTE; MOLECULAR INTERACTION; NEUROPHARMACOLOGY; NOCICEPTION; NOCICEPTIVE RECEPTOR; NONHUMAN; PAIN; PERINEURIUM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SENSORY NERVE CELL; SICKLE CELL ANEMIA;

CELLS; ENDOTHELINS; HUMANS; PAIN; RECEPTORS, ENDOTHELIN;

EID: 79958022694     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2011.02.002     Document Type: Review

References (111)

1. Khodorova A, Montmayeur JP, Strichartz G. Endothelin receptors and pai. J Pain 2009;10(1):4-28.
2. Marasciulo FL, Montagnani M, Potenza MA. Endothelin-1: the yin and yang on vascular function. Curr Med Chem 2006;13(14):1655-65. (Pubitemid 43821697)
3. Penna C, Rastaldo R, Mancardi D, Cappello S, Pagliaro P, Westerhof N. Effect of endothelins on the cardiovascular system. J Cardiovasc Med (Hagerstown) 2006;7(9):645-52. (Pubitemid 44319068)
4. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 1992;13(3):103-8.
5. Sokolovsky M. Endothelins and sarafotoxins: receptor heterogeneity. Int J Biochem 1994;26(3):335-40.
6. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348(6303):730-2. (Pubitemid 120015147)
7. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990;348(6303):732-5. (Pubitemid 120015148)
8. Krystek Jr SR, Patel PS, Rose PM, Fisher SM, Kienzle BK, Lach DA. Mutation of peptide binding site in transmembrane region of a G protein-coupled receptor accounts for endothelin receptor subtype selectivity. J Biol Chem 1994;269(17):12383-6.
9. Rose PM, Krystek Jr SR, Patel PS, Liu EC, Lynch JS, Lach DA. Aspartate mutation distinguishes ETA but not ETB receptor subtype-selective ligand binding while abolishing phospholipase C activation in both receptors. FEBS Lett 1995;361(2-3):243-9.
10. Orry AJ, Wallace BA. Modeling and docking the endothelin G-protein-coupled receptor. Biophys J 2000;79(6):3083-94.
11. Boivin S, Tessier S, Aubin J, Lampron P, Detheux M, Fournier A. Identification of a binding domain of the endothelin-B receptor using a selective IRL-1620-derived photoprobe. Biochemistry 2004;43(36):11516-25. (Pubitemid 39186972)
12. Tessier S, Boivin S, Aubin J, Lampron P, Detheux M, Fournier A. Transmembrane domain V of the endothelin-A receptor is a binding domain of ETA-selective TTA-386-derived photoprobes. Biochemistry 2005;44(21):7844-54. (Pubitemid 40740767)
13. Blandin V, Vigne P, Breittmayer JP, Frelin C. Allosteric inhibition of endothelin ETA receptors by 3,5-dibromosalicylic acid. Mol Pharmacol 2000;58(6):1461-9.
14. Talbodec A, Berkane N, Blandin V, Breittmayer JP, Ferrari E, Frelin C. Aspirin and sodium salicylate inhibit endothelin ETA receptors by an allosteric type of mechanism. Mol Pharmacol 2000;57(4):797-804. (Pubitemid 30183722)
15. Breu V, Hashido K, Broger C, Miyamoto C, Furuichi Y, Hayes A. Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors. Eur J Biochem 1995;231(1):266-70.
16. Davenport AP. International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 2002;54(2):219-26.
17. Jensen N, Hasselblatt M, Siren AL, Schilling L, Schmidt M, Ehrenreich H. ET(A) and ET(B) specific ligands synergistically antagonize endothelin-1 binding to an atypical endothelin receptor in primary rat astrocytes. J Neurochem 1998;70(2):473-82. (Pubitemid 28079335)
18. Hay DW, Luttmann MA, Pullen MA, Nambi P. Functional and binding characterization of endothelin receptors in human bronchus: evidence for a novel endothelin B receptor subtype? J Pharmacol Exp Ther 1998;284(2):669-77.
19. Harada N, Himeno A, Shigematsu K, Sumikawa K, Niwa M. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer. Cell Mol Neurobiol 2002;22(2):207-26.
20. Shibata S, Niwa M, Himeno A, Gana NG, Shigematsu K, Matsumoto M. The endothelin ETA receptor exists in the caudal solitary tract nucleus of the rat brain. Cell Mol Neurobiol 1997;17(1):151-6. (Pubitemid 127714259)
21. Chichorro JG, Fiuza CR, Bressan E, Claudino RF, Leite DF, Rae GA. Endothelins as pronociceptive mediators of the rat trigeminal system: role of ETA and ETB receptors. Brain Res 2010;1345:73-83.
22. Gregan B, Jurgensen J, Papsdorf G, Furkert J, Schaefer M, Beyermann M. Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J Biol Chem 2004;279(26):27679-87. (Pubitemid 38812609)
23. Evans NJ, Walker JW. Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization. Biophys J 2008;95(1):483-92.
24. Evans NJ, Walker JW. Sustained Ca2+ signaling and delayed internalization associated with endothelin receptor heterodimers linked through a PDZ finger. Can J Physiol Pharmacol 2008;86(8):526-35.
25. Ozaki S, Ohwaki K, Ihara M, Ishikawa K, Yano M. Coexpression studies with endothelin receptor subtypes indicate the existence of intracellular cross-talk between ET(A) and ET(B) receptors. J Biochem 1997;121(3):440-7. (Pubitemid 27145897)
26. Ehrenreich H, Anderson RW, Fox CH, Rieckmann P, Hoffman GS, Travis WD. Endothelins, peptides with potent vasoactive properties, are produced by human macrophages. J Exp Med 1990;172(6):1741-8.
27. Kusuhara M, Yamaguchi K, Nagasaki K, Hayashi C, Suzaki A, Hori S. Production of endothelin in human cancer cell lines. Cancer Res 1990;50(11):3257-61. (Pubitemid 20190127)
28. Gandhi CR, Berkowitz DE, Watkins WD. Endothelins. Biochemistry and pathophysiologic actions. Anesthesiology 1994;80(4):892-905.
29. Ahn GY, Butt KI, Jindo T, Yaguchi H, Tsuboi R, Ogawa H. The expression of endothelin-1 and its binding sites in mouse skin increased after ultraviolet B irradiation or local injection of tumor necrosis factor alpha. J Dermatol 1998;25(2):78-84. (Pubitemid 28149924)
30. Peters CM, Lindsay TH, Pomonis JD, Luger NM, Ghilardi JR, Sevcik MA. Endothelin and the tumorigenic component of bone cancer pain. Neuroscience 2004;126(4):1043-52. (Pubitemid 38780907)
31. Yoshizawa T, Kimura S, Kanazawa I, Uchiyama Y, Yanagisawa M, Masaki T. Endothelin localizes in the dorsal horn and acts on the spinal neurones: possible involvement of dihydropyridine-sensitive calcium channels and substance P release. Neurosci Lett 1989;102(2-3):179-84. (Pubitemid 19179787)
32. Giaid A, Gibson SJ, Ibrahim BN, Legon S, Bloom SR, Yanagisawa M. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A 1989;86(19):7634-8. (Pubitemid 19254509)
33. Dymshitz J, Vasko MR. Endothelin-1 enhances capsaicin-induced peptide release and cGMP accumulation in cultures of rat sensory neurons. Neurosci Lett 1994;167(1-2):128-32. (Pubitemid 24077656)
34. Plant TD, Zollner C, Kepura F, Mousa SS, Eichhorst J, Schaefer M. Endothelin potentiates TRPV1 via ETA receptor-mediated activation of protein kinase C. Mol Pain 2007;3:35.
35. 2+ response via activation of endothelin a receptor in a protein kinase Cepsilon-dependent manner in dorsal root ganglion neurons. Neuroscience 2006;137(3):949-60.
36. Zhou QL, Strichartz G, Davar G. Endothelin-1 activates ET(A) receptors to increase intracellular calcium in model sensory neurons. Neuroreport 2001;12(17):3853-7. (Pubitemid 33105185)
37. Gokin AP, Fareed MU, Pan HL, Hans G, Strichartz GR, Davar G. Local injection of endothelin-1 produces pain-like behavior and excitation of nociceptors in rats. J Neurosci 2001;21(14):5358-66. (Pubitemid 32622962)
38. Davar G, Hans G, Fareed MU, Sinnott C, Strichartz G. Behavioral signs of acute pain produced by application of endothelin-1 to rat sciatic nerve. Neuroreport 1998;9(10):2279-83. (Pubitemid 28338221)
39. Fareed MU, Hans G, Atanda A, Strichartz G, Davar G. Pharmacological characterization of acute pain behavior produced by application of endothelin-1 to rat sciatic nerve. J Pain 2000;1:46-53. (Pubitemid 30619641)
40. Pomonis JD, Rogers SD, Peters CM, Ghilardi JR, Mantyh PW. Expression and localization of endothelin receptors: implications for the involvement of peripheral glia in nociception. J Neurosci 2001;21(3):999-1006. (Pubitemid 32163140)
41. Berti-Mattera LN, Gariepy CE, Burke RM, Hall AK. Reduced expression of endothelin B receptors and mechanical hyperalgesia in experimental chronic diabetes. Exp Neurol 2006;201(2):399-406. (Pubitemid 44344232)
42. Zhou Z, Davar G, Strichartz G. Endothelin-1 (ET-1) selectively enhances the activation gating of slowly inactivating tetrodotoxin-resistant sodium currents in rat sensory neurons: a mechanism for the pain-inducing actions of ET-1. J Neurosci 2002;22(15):6325-30. (Pubitemid 35386386)
43. Feng B, Strichartz G. Endothelin-1 raises excitability and reduces potassium currents in sensory neurons. Brain Res Bull 2009;79(6):345-50.
44. Tykocki NR, Watts SW. The interdependence of endothelin-1 and calcium: a review. Clin Sci (Lond) 2010;119(9):361-72.
45. England S, Bevan S, Docherty RJ. PGE2 modulates the tetrodotoxin- resistant sodium current in neonatal rat dorsal root ganglion neurones via the cyclic AMP-protein kinase A cascade. J Physiol 1996;495(Pt 2):429-40. (Pubitemid 26331824)
46. Gold MS, Levine JD, Correa AM. Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci 1998;18(24):10345-55. (Pubitemid 29016554)
47. Cardenas LM, Cardenas CG, Scroggs RS. 5HT increases excitability of nociceptor-like rat dorsal root ganglion neurons via cAMP-coupled TTX-resistant Na(+) channels. J Neurophysiol 2001;86(1):241-8. (Pubitemid 32623229)
48. Lai J, Porreca F, Hunter JC, Gold MS. Voltage-gated sodium channels and hyperalgesia. Annu Rev Pharmacol Toxicol 2004;44:371-97. (Pubitemid 38263846)
49. Stosser S, Agarwal N, Tappe-Theodor A, Yanagisawa M, Kuner R. Dissecting the functional significance of endothelin A receptors in peripheral nociceptors in vivo via conditional gene deletion. Pain 2010;148(2):206-14.
50. Khodorova A, Navarro B, Jouaville LS, Murphy JE, Rice FL, Mazurkiewicz JE. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat Med 2003;9(8):1055-61. (Pubitemid 37021786)
51. Bagnato A, Venuti A, Di Castro V, Marcante ML. Identification of the ETA receptor subtype that mediates endothelin induced autocrine proliferation of normal human keratinocytes. Biochem Biophys Res Commun 1995;209(1):80-6.
52. Tsuboi R, Sato C, Oshita Y, Hama H, Sakurai T, Goto K, et al. Ultraviolet B irradiation increases endothelin-1 and endothelin receptor expression in cultured human keratinocytes. FEBS Lett 1995;371(2):188-90.
53. Zhao P, Barr TP, Hou Q, Dib-Hajj SD, Black JA, Albrecht PJ, et al. Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: evidence for a role in pain. Pain 2008;139(1):90-105.
54. Loeser JD, Treede RD. The Kyoto protocol of IASP basic pain terminology. Pain 2008;137(3):473-7.
55. Menendez L, Andres-Trelles F, Hidalgo A, Baamonde A. Opioid footshock-induced analgesia in mice acutely falls by stress prolongation. Physiol Behav 1993;53(6):1115-9. (Pubitemid 23167529)
56. da Cunha JM, Rae GA, Ferreira SH, Cunha Fde Q. Endothelins induce ETB receptor-mediated mechanical hypernociception in rat hindpaw: roles of cAMP and protein kinase C. Eur J Pharmacol 2004;501(1-3):87-94. (Pubitemid 39298940)
57. Balonov K, Khodorova A, Strichartz GR. Tactile allodynia initiated by local subcutaneous endothelin-1 is prolonged by activation of TRPV-1 receptors. Exp Biol Med (Maywood) 2006;231(6):1165-70. (Pubitemid 43845598)
58. Kawamata T, Ji W, Yamamoto J, Niiyama Y, Furuse S, Namiki A. Contribution of transient receptor potential vanilloid subfamily 1 to endothelin-1-induced thermal hyperalgesia. Neuroscience 2008;154(3):1067-76.
59. Motta EM, Chichorro JG, D'Orleans-Juste P, Rae GA. Roles of endothelin ETA and ETB receptors in nociception and chemical, thermal and mechanical hyperalgesia induced by endothelin-1 in the rat hindpaw. Peptides 2009;30(5):918-25.
60. Caterina MJ, Julius D. The vanilloid receptor: amolecular gateway to the pain pathway. Annu Rev Neurosci 2001;24:487-517. (Pubitemid 32695237)
61. Premkumar LS, Ahern GP. Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000;408(6815):985-90. (Pubitemid 32101646)
62. Sugiura T, Tominaga M, Katsuya H, Mizumura K. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1. J Neurophysiol 2002;88(1):544-8. (Pubitemid 34755376)
63. Moriyama T, Iida T, Kobayashi K, Higashi T, Fukuoka T, Tsumura H. Possible involvement of P2Y2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J Neurosci 2003;23(14):6058-62. (Pubitemid 36868990)
64. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9(7):484-96.
65. Chichorro JG, Zampronio AR, Cabrini DA, Franco CR, Rae GA. Mechanisms operated by endothelin ETA and ETB receptors in the trigeminal ganglion contribute to orofacial thermal hyperalgesia induced by infraorbital nerve constriction in rats. Neuropeptides 2009;43(2):133-42.
66. Kawamata T, Ji W, Yamamoto J, Niiyama Y, Furuse S, Omote K. Involvement of transient receptor potential vanilloid subfamily 1 in endothelin-1-induced pain-like behavior. Neuroreport 2009;20(3):233-7.
67. Rathee PK, Distler C, Obreja O, Neuhuber W, Wang GK, Wang SY. PKA/AKAP/VR-1 module: a common link of Gs-mediated signaling to thermal hyperalgesia. J Neurosci 2002;22(11):4740-5. (Pubitemid 37465689)
68. Prescott ED, Julius D. A modular PIP2 binding site as a determinant of capsaicin receptor sensitivity. Science 2003;300(5623):1284-8. (Pubitemid 36618238)
69. 2+/calmodulin-dependent kinase II regulates its vanilloid binding. J Biol Chem 2004;279(8):7048-54.
70. Motta EM, Chichorro JG, Rae GA. Role of ET(A) and ET(B) endothelin receptors on endothelin-1-induced potentiation of nociceptive and thermal hyperalgesic responses evoked by capsaicin in rats. Neurosci Lett 2009;457(3):146-50.
71. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 2003;112(6):819-29. (Pubitemid 36378884)
72. Bautista DM, Movahed P, Hinman A, Axelsoon HE, Sterner O, Hogestatt ED. Pungent products from garlic activate the sensory ion channel TRPA1. Proc Natl Acad Sci U S A 2005;102(34):12248-52.
73. Bautista DM, Jordt SE, Nikai T, Tsuruda PR, Read AJ, Poblete J. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 2006;124(6):1269-82.
74. Katsura H, Obata K, Mizushima T, Yamanaka H, Kobayashi K, Dai Y. Antisense knockdownof TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats. Exp Neurol 2006;200(1):112-23. (Pubitemid 44080752)
75. Kwan KY, Allchorne AJ, Vollrath MA, Christensen AP, Zhang DS, Zhang DS. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron 2006;50(2):277-89.
76. Obata K, Katsura H, Mizushima T, Yamanaka H, Kobayashi K, Dai Y. TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J Clin Invest 2005;115(9):2393-401. (Pubitemid 41266201)
77. Liang J, Bi H, Ji W. Involvement of TRPA1 in ET-1-induced pain-like behavior in mice. Neuroreport 2010;21(3):201-5.
78. Ferreira SH, Romitelli M, de Nucci G. Endothelin-1 participation in overt and inflammatory pain. J Cardiovasc Pharmacol 1989;13(Suppl. 5):S220-2.
79. Dahlof B, Gustafsson D, Hedner T, Jern S, Hansson L. Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J Hypertens 1990;8(9):811-7. (Pubitemid 20329766)
80. Namer B, Hilliges M, Orstavik K, Schmidt R, Weidner C, Torebjork E. Endothelin 1 activates and sensitizes human C-nociceptors. Pain 2008;137(1):41-9. (Pubitemid 351794398)
81. McKelvy AD, Sweitzer SM. Endothelin-1 exposure on postnatal day 7 alters expression of the endothelin B receptor and behavioral sensitivity to endothelin-1 on postnatal day 11. Neurosci Lett 2009;451(1):89-93.
82. McKelvy AD, Sweitzer SM. Decreased opioid analgesia inweanling rats exposed to endothelin-1 during infancy. Neurosci Lett 2009;466(3):1448.
83. Khodorova A, Strichartz GR. Remarkably long-lasting tachyphylaxis of pain responses to ET-1: evidence against central nervous system involvement. Can J Physiol Pharmacol 2010;88(6):668-75.
84. Janig W, Baron R. Complex regional pain syndrome: mystery explained? Lancet Neurol 2003;2(11):687-97.
85. Blaes F, Tschernatsch M, Braeu ME, Matz O, Schmitz K, Nascimento D. Autoimmunity in complex-regional pain syndrome. Ann N Y Acad Sci 2007;1107:168-73. (Pubitemid 47528793)
86. Huygen FJ, de Bruijn AG, Klein J, Zijlstra FJ. Neuroimmune alterations in the complex regional pain syndrome. Eur J Pharmacol 2001;429(1-3):101-13. (Pubitemid 33043986)
87. Eisenberg E, Erlich T, Zinder O, Lichinsky S, Diamond E, Pud D. Plasma endothelin-1 levels in patients with complex regional pain syndrome. Eur J Pain 2004;8(6):533-8. (Pubitemid 39504957)
88. Munts AG, Zijlstra FJ, Nibbering PH, Daha MR, Marinus J, Dahan A. Analysis of cerebrospinal fluid inflammatory mediators in chronic complex regional pain syndrome related dystonia. Clin J Pain 2008;24(1):30-4.
89. Groeneweg JG, Huygen FJ, Heijmans-Antonissen C, Niehof S, Zijlstra FJ. Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1. BMC Musculoskelet Disord 2006;7:91.
90. Patel JN, Jager A, Schalkwijk C, Corder R, Douthwaite JA, Yudkin JS. Effects of tumour necrosis factor-alpha in the human forearm: blood flow and endothelin-1 release. Clin Sci (Lond) 2002;103(4):409-15. (Pubitemid 35193246)
91. Matsushima H, Yamada N, Matsue H, Shimada S. The effects of endothelin-1 on degranulation, cytokine, and growth factor production by skin-derived mast cells. Eur J Immunol 2004;34(7):1910-9. (Pubitemid 39268779)
92. Kramer HH, Schmidt K, Leis S, Schmelz M, Sommer C, Birklein F. Inhibition of neutral endopeptidase (NEP) facilitates neurogenic inflammation. Exp Neurol 2005;195(1):179-84. (Pubitemid 41121975)
93. Kramer HH, He L, Lu B, Birklein F, Sommer C. Increased pain and neurogenic inflammation in mice deficient of neutral endopeptidase. Neurobiol Dis 2009;35(2):177-83.
94. Coderre TJ, Xanthos DN, Francis L, Bennett GJ. Chronic post-ischemia pain (CPIP): a novel animal model of complex regional pain syndrome-type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat. Pain 2004;112(1-2):94-105. (Pubitemid 39371024)
95. Millecamps M, Laferriere A, Ragavendran JV, Stone LS, Coderre TJ. Role of peripheral endothelin receptors in an animal model of complex regional pain syndrome type 1 (CRPS-I). Pain 2010;151(1):174-83.
96. Wacnik PW, Eikmeier LJ, Ruggles TR, Ramnaraine MS, Walchek BK, Beitz AJ. Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci 2001;21(23):9355-66. (Pubitemid 33096879)
97. Schmidt BL, Pickering V, Liu S, Quang P, Dolan J, Connelly ST. Peripheral endothelin A receptor antagonism attenuates carcinoma-induced pain. Eur J Pain 2007;11(4):406-14. (Pubitemid 46366762)
98. Pickering V, Jay Gupta R, Quang P, Jordan RC, Schmidt BL. Effect of peripheral endothelin-1 concentration on carcinoma-induced pain in mice. Eur J Pain 2008;12(3):293-300. (Pubitemid 351249881)
99. Fujita M, Andoh T, Saiki I, Kuraishi Y. Involvement of endothelin and ET(A) endothelin receptor in mechanical allodynia in mice given orthotopic melanoma inoculation. J Pharmacol Sci 2008;106(2):257-63. (Pubitemid 351366345)
100. Yuyama H, Koakutsu A, Fujiyasu N, Tanahashi M, Fujimori A, Sato S. Effects of selective endothelin ET(A) receptor antagonists on endothelin-1-induced potentiation of cancer pain. Eur J Pharmacol 2004;492(2-3):177-82. (Pubitemid 38721369)
101. Quang PN, Schmidt BL. Endothelin-A receptor antagonism attenuates carcinoma-induced pain through opioids in mice. J Pain 2010;11(7):663-71.
102. Bagnato A, Rosano L. The endothelin axis in cancer. Int J Biochem Cell Biol 2008;40(8):1443-51.
103. Nelson JB, Lee WH, Nguyen SH, Jarrard DF, Brooks JD, Magnuson SR. Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res 1997;57(1):35-7.
104. Hoosein MM, Dashwood MR, Dawas K, Ali HM, Grant K, Savage F. Altered endothelin receptor subtypes in colorectal cancer. Eur J Gastroenterol Hepatol 2007;19(9):775-82. (Pubitemid 47266706)
105. Quang PN, Schmidt BL. Peripheral endothelin B receptor agonist-induced antinociception involves endogenous opioids in mice. Pain 2010;149(2):254-62.
106. Cain DM, Wacnik PW, Eikmeier L, Beitz A, Wilcox GL, Simone DA. Functional interactions between tumor and peripheral nerve in a model of cancer pain in the mouse. Pain Med 2001;2(1):15-23. (Pubitemid 32447627)
107. Hamamoto DT, Khasabov SG, Cain DM, Simone DA. Tumor-evoked sensitization of C nociceptors: a role for endothelin. J Neurophysiol 2008;100(4):2300-11.
108. Djouhri L, Koutsikou S, Fang X, McMullan S, Lawson SN. Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci 2006;26(4):1281-92. (Pubitemid 43239574)
109. Schouenborg J, Dickenson A. Effects of a distant noxious stimulation on A and C fibre-evoked flexion reflexes and neuronal activity in the dorsal horn of the rat. Brain Res 1985;328(1):23-32. (Pubitemid 15146758)
110. Caterina MJ, Julius D. Sense and specificity: a molecular identity for nociceptors. Curr Opin Neurobiol 1999;9(5):525-30. (Pubitemid 29484374)
111. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389(6653):816-24. (Pubitemid 27462969)